MAP2K7 and cancer: These findings showed that docetaxel-mediated stromal injury and cytokine release activates MEK/ERK signaling in cancer cells resulting in cancer dormancy awakening and that MEK/ERK signaling blockade prevents cancer dormancy outgrowth.